Nadeem R Abu-Rustum

28PUBLICATIONS
105CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 20, 2025
Evolution and Co-occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level.

Arnaud Da Cruz Paula, Yingjie Zhu, David N Brown

|Mar 26, 2025
Trachelectomy and Cerclage Placement as Fertility-Sparing Surgery for Cervical Cancer-An Expert Survey.

Anke Smits, Janneke T Wolswinkel, Mieke L G Ten Eikelder

|Aug 29, 2024
Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial.

Nicolò Bizzarri, Nadeem R Abu-Rustum, Marie Plante

|Jul 29, 2024
Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study.

Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi

|Jul 29, 2024
2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.

Eric Rios-Doria, Nadeem R Abu-Rustum, Gretchen Glaser

|Jul 01, 2024
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study.

Ryan M Kahn, Thomas Boerner, Michael Kim

Pageof 5